BioNTech SE (BNTX)

Nasdaq · Healthcare · Biotechnology
$80.96-0.52%As of 2026-11-22 · USD
Last session low $80.27Last session high $82.86
52-week low $79.5252-week high $124.00
Market cap
$20.07B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)31.1In the neutral range (30 to 70)
MACD (12, 26, 9)-2.52Below its signal line (-2.17); histogram -0.35
Bollinger %B (20, 2)-7%Below the lower band (81.58 to 91.04)
SMA 2086.31Price is 6.2% below
SMA 5091.51Price is 11.5% below
SMA 20095.09Price is 14.9% below
ATR (20)3.45% of priceAverage true range per day
52-week position3%In the lower part of the 79.52 to 124.00 range

About BioNTech SE

BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus.

Latest fiscal yearEnded 2025-12-31: revenue of 2.87B EUR and an operating margin of -22.3%.

More in Biotechnology